Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: April 2025

MHRA approves prostate cancer imaging agent trofolastat

MHRA approves prostate cancer imaging agent trofolastat
p p Read More

Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK

April 8, 2025 MHRA, News, prostate cancer, RoTecPSMA, trofolastat

Surgeon who sexually harassed colleagues has suspension extended to 12 months

A consultant surgeon who sexually harassed junior female colleagues has been suspended from the medical register for 12 […]

April 8, 2025 Uncategorized

AI in healthcare: what does good evidence and regulation look like?

How are AI tools being evaluated?So far, the UK National Institute for Health and Care Excellence (NICE) has […]

April 8, 2025 Uncategorized

Trump watch: 23 states and 2000 scientists sue president over cuts, WHO budget crisis deepens, and more

DC and 23 states sue Trump governmentThe District of Columbia and 23 US states have launched legal action […]

April 8, 2025 Obstetrics and gynaecology, US

Researchers use AI to improve diagnosis of drug-resistant infections

Scientists have developed an artificial intelligence-based method to more accurately detect antibiotic resistance in deadly bacteria such as […]

April 8, 2025 Uncategorized

Maternal mortality falls 40% worldwide, but funding cuts could reverse progress, says UN

Concerted global efforts to improve maternal healthcare mean that women are far less likely to die in childbirth […]

April 7, 2025 Obstetrics and gynaecology, Paediatrics

Racialised health inequalities in maternity care

The inequalities in outcomes for pregnant women and babies from black and Asian backgrounds have been improving, but […]

April 7, 2025 Uncategorized

Endlyz Therapeutics emerges with pipeline for Parkinson’s disease

Endlyz Therapeutics emerges with pipeline for Parkinson’s disease
p p Read More

Research targets lysosomal function restoration for neurodegeneration

April 7, 2025 News

SMC approves bimekizumab for hidradenitis suppurativa treatment

SMC approves bimekizumab for hidradenitis suppurativa treatment
p p Read More

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) […]

April 7, 2025 News

Changes to the disability benefits system need to prioritise evidence over short term cost savings

The debate over rising numbers of people claiming disability benefits in the United Kingdom, particularly relating to mental […]

April 5, 2025 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 8 9 10 … 13 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy